Search - tctmd.com

Displaying 201 - 220 of 323

Sort: Relevancy | Date

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Daily News

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

Caitlin E. Cox

May 26, 2016

News Daily News

Early Angiography in Cardiac Arrest Patients Beneficial Even in Those Lacking ST-Segment Elevation

Caitlin E. Cox

May 05, 2016

News Daily News

Very Elderly STEMI Patients Do Better With PCI, but ‘Eyeballing’ Is Insufficient for Decision Making

L.A. McKeown

May 02, 2016

News Daily News

Using Coronary CTA as Gatekeeper Test in Suspected Angina Linked to Better Outcomes: SCOT-HEART

Todd Neale

April 15, 2016

News Conference News ACC 2016

Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding

Todd Neale

April 06, 2016

News Daily News

完全血运重建会减少多支 CAD 的死亡、心梗、再次手术事件：Meta 分析

Michael O'Riordan

January 21, 2016

News Daily News

Meta Análisis: La Revascularización Completa Reduce la Mortalidad, los IM y las Nuevas Intervenciones en la EAC Multivaso

Michael O'Riordan

January 21, 2016

News Daily News

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-Analysis

Michael O'Riordan

January 21, 2016

News Daily News

Two New Studies Strengthen Case Against Thrombus Aspiration in STEMI

Todd Neale

January 20, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Yael L. Maxwell

January 05, 2016

News Daily News

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Michael O'Riordan

December 15, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Caitlin E. Cox

December 15, 2015

News Daily News

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

Caitlin E. Cox

December 15, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Meta-Analysis Boosts Case for Increased Use of Radial Access

November 29, 2015

News Conference News TCT 2015

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

October 14, 2015

News Conference News TCT 2015

INNOVATION Study Suggests Safety of Deferred Stenting

October 13, 2015

Advertisement

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

Early Angiography in Cardiac Arrest Patients Beneficial Even in Those Lacking ST-Segment Elevation

Very Elderly STEMI Patients Do Better With PCI, but ‘Eyeballing’ Is Insufficient for Decision Making

Using Coronary CTA as Gatekeeper Test in Suspected Angina Linked to Better Outcomes: SCOT-HEART

Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding

完全血运重建会减少多支 CAD 的死亡、心梗、再次手术事件：Meta 分析

Meta Análisis: La Revascularización Completa Reduce la Mortalidad, los IM y las Nuevas Intervenciones en la EAC Multivaso

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-Analysis

Two New Studies Strengthen Case Against Thrombus Aspiration in STEMI

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Meta-Analysis Boosts Case for Increased Use of Radial Access

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

INNOVATION Study Suggests Safety of Deferred Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content